Tag Archives: Tysabri

FDA’s REMS Drug Safety Program Sometimes Confusing To Patients, And A Barrier To Drug Access: Study

January 24, 2022 By: Martha Garcia

Some patients believe the program is actually set up to benefit drug companies.
Side Effects of Rituxan for MS Treatment May Carry Increased Infection Risks: Study

October 15, 2019 By: Martha Garcia
Tysabri PML Risk-Minimization Strategies Working, Study Finds

September 16, 2019 By: Martha Garcia
Commonly Used Drugs Linked To Four Serious Adverse Side Effects: ISMP Report

October 02, 2018 By: Irvin Jackson
Tysabri PML Infection Risk Increases With Long-Term Use: Study

October 17, 2017 By: Irvin Jackson
Tysabri Brain Infection Side Effects Could Be Mitigated By Early Detection Through MRIs: Study

January 19, 2017 By: Irvin Jackson
Tysabri Lawsuit Claims Manufacturer Delayed PML Brain Test To Maximize Profits

June 16, 2016 By: Irvin Jackson
Tecfidera Brain Infection Results in FDA Warning Label Update

November 26, 2014 By: Irvin Jackson
Tecfidera Linked to Case of PML Brain Infection

October 23, 2014 By: Irvin Jackson
Jakafi Risks Require Monitoring of Dose During First Three Months: Study

December 30, 2013 By: Irvin Jackson

Lawyers Identify 15 Bard PowerPort Injury Lawsuits for Next Phase of Bellwether Trial Discovery (Posted 6 days ago)

The Bard PowerPort lawsuits will go through additional fact specific discovery over the next few months, before the parties determine which six will serve best as early bellwether trials.

Lawyers in Hair Relaxer Cancer Lawsuits Fail To Reach Agreement on Bellwether Plan (Posted 7 days ago)

Judge presiding over all federal hair relaxer lawsuits has ordered the parties to submit separate briefing on the bellwether selection process by January 3.

Depo-Provera Lawsuit MDL Application Will Be Considered by JPML at Hearing on Jan. 30, 2025 (Posted 8 days ago)

With a growing number of women pursuing Depo-Provera brain tumor lawsuits throughout the federal court system, the U.S. JPML will decide whether to consolidate and centralize the claims before one judge for coordinated discovery and pretrial proceedings.

Tag Archives: Tysabri

FDA’s REMS Drug Safety Program Sometimes Confusing To Patients, And A Barrier To Drug Access: Study

Side Effects of Rituxan for MS Treatment May Carry Increased Infection Risks: Study

Tysabri PML Risk-Minimization Strategies Working, Study Finds

Commonly Used Drugs Linked To Four Serious Adverse Side Effects: ISMP Report

Tysabri PML Infection Risk Increases With Long-Term Use: Study

Tysabri Brain Infection Side Effects Could Be Mitigated By Early Detection Through MRIs: Study

Tysabri Lawsuit Claims Manufacturer Delayed PML Brain Test To Maximize Profits

Tecfidera Brain Infection Results in FDA Warning Label Update

Tecfidera Linked to Case of PML Brain Infection

Jakafi Risks Require Monitoring of Dose During First Three Months: Study

More Top Stories

Review A Case